Literature DB >> 26312648

Long-term remission of corticosteroid- and cyclophosphamide-resistant Henoch-Schönlein purpura with rituximab.

M Bellan1,2, M Pirisi1,2,3, P P Sainaghi2,3.   

Abstract

Entities:  

Year:  2015        PMID： 26312648     DOI： 10.3109/03009742.2015.1058417

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  5 in total

1.  Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis.

Authors:  Akira Mima
Journal:  Rheumatol Int       Date:  2017-03-02       Impact factor: 2.631

Review 2.  Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature.

Authors:  Roberta Fenoglio; Carla Naretto; Bruno Basolo; Giacomo Quattrocchio; Michela Ferro; Paola Mesiano; Giulietta Beltrame; Dario Roccatello
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 3.  Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature.

Authors:  Courtney B Crayne; Esraa Eloseily; Melissa L Mannion; Saji P Azerf; Peter Weiser; Timothy Beukelman; Matthew L Stoll; Daniel I Feig; T Prescott Atkinson; Randy Quentin Cron
Journal:  Pediatr Rheumatol Online J       Date:  2018-11-14       Impact factor: 3.054

Review 4.  Vasculitis: A Checklist to Approach and Treatment Update for Dermatologists.

Authors:  Prabhakar M Sangolli; Dammaningala Venkataramaiah Lakshmi
Journal:  Indian Dermatol Online J       Date:  2019-11-01

Review 5.  Individualized medication based on pharmacogenomics and treatment progress in children with IgAV nephritis.

Authors:  Xuerong Yang; Qi Li; Yuanyuan He; Yulian Zhu; Rou Yang; Xiaoshi Zhu; Xi Zheng; Wei Xiong; Yong Yang
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.